Patil Susheel P, Krishnan Jerry A, Lechtzin Noah, Diette Gregory B
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, 1830 E Monument Street, Suite 7110 A, Baltimore, MD 21205, USA.
Arch Intern Med. 2003 May 26;163(10):1180-6. doi: 10.1001/archinte.163.10.1180.
Acute exacerbations of chronic obstructive pulmonary disease (COPD) are a frequent cause of hospitalization in the United States. Previous studies of selected populations of patients with COPD have estimated in-hospital mortality to range from 4% to 30%. Our objective was to obtain a generalizable estimate of in-hospital mortality from acute exacerbation of COPD in the United States and to identify predictors of in-hospital mortality using administrative data.
We performed a cross-sectional study utilizing the 1996 Nationwide Inpatient Sample, a data set of all hospitalizations from a 20% sample of nonfederal US hospitals. The study population included 71 130 patients aged 40 years or older with an acute exacerbation of COPD at hospital discharge. The primary outcome assessed was in-hospital mortality.
In-hospital mortality for patients with an acute exacerbation of COPD was 2.5%. Multivariable analyses identified older age, male sex, higher income, nonroutine admission sources, and more comorbid conditions as independent risk factors for in-hospital mortality.
Mortality during hospitalization in this nationwide sample of patients with acute exacerbations of COPD was lower than that of previous studies of select populations. This estimate should provide optimism to both clinicians and patients regarding prognoses from COPD exacerbations requiring hospitalization. Our results indicate that the use of administrative data can help to identify subsets of patients with acute exacerbations of COPD that are at higher risk of in-hospital mortality.
在美国,慢性阻塞性肺疾病(COPD)急性加重是住院的常见原因。先前针对特定COPD患者群体的研究估计,住院死亡率在4%至30%之间。我们的目标是获得美国COPD急性加重患者住院死亡率的可推广估计值,并使用行政数据确定住院死亡率的预测因素。
我们利用1996年全国住院患者样本进行了一项横断面研究,该数据集来自美国20%非联邦医院的所有住院病例。研究人群包括71130名40岁及以上在出院时患有COPD急性加重的患者。评估的主要结局是住院死亡率。
COPD急性加重患者的住院死亡率为2.5%。多变量分析确定年龄较大、男性、收入较高、非常规入院来源以及更多合并症是住院死亡率的独立危险因素。
在这个全国性的COPD急性加重患者样本中,住院期间的死亡率低于先前针对特定人群的研究。这一估计值应能让临床医生和患者对因COPD加重需要住院治疗的预后感到乐观。我们的结果表明,使用行政数据有助于识别COPD急性加重且住院死亡风险较高的患者亚组。